Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Premium Services
Financial News
Latest
Earnings
Guidance
Dividends
M&A
Buybacks
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Small-Cap
Markets
Pre-Market
After Hours
Movers
ETFs
Options
Cryptocurrency
Commodities
Bonds
Futures
Mining
Real Estate
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Investing Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
Analyst Ratings
Analyst Color
Latest Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Unusual Options Activity Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Compare Best Stocks

Best Momentum Stocks

Best Quality Stocks

Best Value Stocks

Best Growth Stocks

Comments

Loading...

BioStem Technologies Stock News

BSEMOTCID

Logo brought to you by Benzinga Data

Trade with Public

Trade with Public

$3.95

-0.19-4.59%

At close: Dec 15, 4:00 PM EST

News

Latest BioStem Technologies Stock News | OTC:BSEM | Benzinga

Get the latest news on BioStem Technologies stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on BioStem Technologies performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Thursday, May 01, 2025

BioStem to Highlight BioREtain Tech And Prese...
Benzinga Newsdesk

Wednesday, January 08, 2025

Biostem Technologies Announces The Initiation...
Lekha Gupta

Monday, September 11, 2023

NovaBay Pharmaceuticals Announces Agreement w...
Benzinga Newsdesk

Monday, January 30, 2023

How BioStem Plans To Grow Its Perinatal Allografts In 2023 – And Beyond
Gita Karunakaran - Sponsored

Monday, January 23, 2023

BioStem Reveals Plans For New Products, Expanded Sales And Manufacturing Capabilities At Dawson James Small Cap Growth Conference
Rachael Green - Sponsored

Tuesday, January 17, 2023

Benzinga Speaks To BioStem Technologies About How Its Technology Is Changing The World Of Wound Care
Faith Ashmore - Sponsored

Friday, January 13, 2023

2022 Year in Review: BioStem Technologies Looks Back At A Year of Growth And Expansion
Gita Karunakaran - Sponsored

Monday, November 07, 2022

Zacks Investment Research Initiates Coverage ...
Benzinga Newsdesk

Thursday, September 22, 2022

BioStem Technologies (OTCMKTS: BSEM) Coverage Initiated at Zacks Investment Research
Zacks Small Cap Research

Friday, September 09, 2022

BioStem Technologies, Inc. Second Quarter Financial Results Call, August 22, 2022
BioStem Technologies

Thursday, September 08, 2022

BioStem Technologies Reports 133% Year-Over-Year Revenue Growth As It Expands Distribution of Patented Allograft Tech
Rachael Green - Sponsored

Thursday, June 23, 2022

BioStem Technologies' Local MicroEnvironment Activation Possible Key To Reversing And Repairing Diseases-Caused Tissue Damage
Jacinta Sherris

Friday, June 17, 2022

Benzinga Announces This Week's All Access Guests
Kenneth Adams

Monday, May 16, 2022

EXCLUSIVE: BioStem Technologies Reports Q1 Net Revenue Up 211% YoY
Michael Cohen

Thursday, April 22, 2021

Cannabis Movers & Shakers: Halo Collective, Suite 420 Access, OWP, BioStem, Chicago Atlantic Advisors, Silo Wellness
Jelena Martinovic

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investors Events
Pre market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved